Ocugen (OCGN) Other Working Capital Changes (2014 - 2026)
Ocugen (OCGN) posted Other Working Capital Changes of -$317000.0 for Q1 2026, up 75.93% on a QoQ basis from -$1.3 million in Q4 2025, and down 62.56% year-over-year from -$846780.8 in Q1 2025.
Ocugen (OCGN) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Ocugen's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$317000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 62.56% year-over-year to -$317000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 51.74% YoY) and the FY2025 annual result came in at -$1.2 million, down 47.3% from the prior year.
- Other Working Capital Changes was -$317000.0 for Q1 2026 at Ocugen, up from -$1.3 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.0 million in Q1 2025 and bottomed at -$1.8 million in Q3 2022.
- A 5-year average of $198705.9 and a median of $117000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes sank 3350.0% — and 2025, when it surged 273.67%.
- Ocugen's Other Working Capital Changes stood at -$122000.0 in 2022, then declined by 10.66% to -$135000.0 in 2023, then plunged by 60.0% to -$216000.0 in 2024, then sank by 509.72% to -$1.3 million in 2025, then jumped by 75.93% to -$317000.0 in 2026.
- Business Quant data shows OCGN's Other Working Capital Changes at -$317000.0 in Q1 2026, -$1.3 million in Q4 2025, and $686000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 927,000.00 |
| Mar 31, 2026 | 927,000.00 |
| Mar 31, 2026 | 927,000.00 |
| Dec 31, 2025 | 694,000.00 |
| Dec 31, 2025 | 694,000.00 |
| Dec 31, 2025 | 694,000.00 |
| Sep 30, 2025 | -795,000.00 |
| Sep 30, 2025 | -795,000.00 |
| Sep 30, 2025 | -795,000.00 |
| Jun 30, 2025 | -294,000.00 |
| Jun 30, 2025 | -294,000.00 |
| Jun 30, 2025 | -294,000.00 |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Sep 30, 2024 | -1.13 Mn |